Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q1 2025 Earnings

13MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.17

-0.03

0.1

0.24

Details

Expected EPS

-0.17

Actual EPS

-0.03

Surprise EPS

0.14

Surprise Percent

+82.35%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.03 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.